Diabetes, coronary intervention, and platelet glycoprotein IIb/IIIa blockade: the triad revisited.
Circulation, 2004/12/14;110(24):3618-20.
PMID: 15596556
Impact factor: 39.918
MeSH terms
Abciximab; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Coronary Artery Disease; Coronary Restenosis; Diabetes Complications; Fibrinolytic Agents; Humans; Immunoglobulin Fab Fragments; Myocardial Infarction; Platelet Glycoprotein GPIIb-IIIa Complex; Randomized Controlled Trials as Topic
More resources
EndNote: Download